Related Experiment Video
Updated: Jun 7, 2025

07:13
Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
Published on: April 20, 2021
3.9K
Development of a Deep Learning Model for Classification of Hepatic Steatosis from Clinical Standard Ultrasound
Ahmed El Kaffas1, Krishna Chaitanya Bhatraju2, Jenny M Vo-Phamhi2
1Department of Radiology, University of California San Diego School of Medicine, La Jolla, CA, USA.
Ultrasound in Medicine & Biology
|November 13, 2024
Summary
A deep learning program accurately detects hepatic steatosis (fatty liver) using standard ultrasound images. This AI tool aids in early diagnosis and monitoring of liver disease progression.
Area of Science:
- Medical Imaging
- Artificial Intelligence in Medicine
- Hepatology
Background:
- Early detection of hepatic steatosis is crucial for preventing disease advancement.
- Standard grayscale ultrasound (US) is a common diagnostic tool.
- Deep learning (DL) offers potential for automated image analysis.
Purpose of the Study:
- To develop a DL program for classifying hepatic steatosis from US images.
- To differentiate normal liver from steatotic liver.
- To categorize steatosis severity (mild vs. moderate/severe).
Main Methods:
- Retrospective study using 403 grayscale US exams (2010-2022).
- Dataset labeled with magnetic resonance imaging proton density fat fraction (MRI-PDFF).
- Developed DL multi-instance models for binary and multi-class classification.
Main Results:
- The S0/1 vs. S2/3 model achieved 95.9% AUC, demonstrating high accuracy in distinguishing moderate/severe steatosis.
- The S0 vs. S1/2/3 model showed 81.3% AUC for detecting any steatosis.
- Multi-class model provided accurate classification across different steatosis grades.
Conclusions:
- The developed DL program demonstrates high sensitivity and accuracy for hepatic steatosis detection and categorization.
- This AI tool can enhance the utility of standard ultrasound for liver fat assessment.
- Potential for improved early diagnosis and management of fatty liver disease.

